Canadian Partner Writes Down Value Of Epican
http://jamaica-gleaner.com/article/b...n-value-epican
THE CANADIAN partner in Epican Medicinals Limited has scaled back its market expectations for Jamaica and shelved plans to export weed from the island.
The Green Organic Dutchman, TGOD, disclosed in its March financials a CDN$4.3-million ($430-million) non-cash impairment on the Epican investment.
The impairment reflects an expectation that TGOD’s investments are unlikely to be recovered in full in Jamaica and Canada due to market conditions. The company did not describe the precise factors around the writedown, and Epican has not responded to requests for comment. However, the cannabis market is experiencing increased formal and informal competition and prices are under pressure.
“The balance of CDN$4.3 million non-cash impairment charge related to our investment in Epican in Jamaica, due to market conditions there and our strategic decision to forgo the expansion of proposed cultivation activities for export, in order to focus on our Canadian operations,” said Sean Bovingdon, chief financial officer, at TGOD in an investor conference call.
Instead of importing cannabis from Jamaica, TGOD will sell product from its recently finished facility at Ancaster in Canada and will also import hemp from Europe.
Comment